Actively Recruiting
Real-World Study of Ruxolitinib Phosphate Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo Affecting the Face
Led by ShanShan Li · Updated on 2026-09-08
300
Participants Needed
20
Research Sites
108 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of topical 1.5% Ruxolitinib phosphate cream combined with systemic corticosteroids in patients aged 12 years and older who have active, progressive non-segmental vitiligo affecting the face. This prospective, multicenter, real-world observational study aims to assess the clinical effectiveness and safety of this combined treatment approach. The primary focus is on measuring improvement in facial vitiligo patches after 12 weeks of therapy. Participants will apply Ruxolitinib cream twice daily to affected skin areas for up to 24 weeks. Alongside this, they will receive corticosteroid therapy either by monthly intramuscular Compound Betamethasone injections or low-dose oral Dexamethasone pulses on weekends, also for a maximum of 24 weeks. Treatments are prescribed following standard clinical care practices, and the study plans to enroll 300 patients to monitor real-world outcomes. During the study, participants will be regularly followed up to evaluate improvements using the Facial Vitiligo Area Scoring Index F-VASI and other measures at multiple timepoints, including weeks 4, 8, 12, and 24. Safety and side effects will be monitored throughout the 24-week treatment. The main outcome is the proportion of patients achieving at least 75% improvement in facial vitiligo after 12 weeks. Overall, the study spans from initial treatment through to detailed clinical assessments and safety monitoring.
CONDITIONS
Brief Title
Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study
Research Team
S
ShanShan Li
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here